There were 118 press releases posted in the last 24 hours and 399,263 in the last 365 days.

$312M Stable Isotope Labeled Compounds Market Outlook, 2024

Dublin, Jan. 23, 2020 (GLOBE NEWSWIRE) -- The "Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region - Global Forecast to 2024" report has been added to's offering.

  • This report analyzes the stable isotope labeled compounds market and aims at estimating the market size and future growth potential.
  • The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3%.

The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.

The prominent players operating in the global stable isotope labeled compounds market include PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).

By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.

Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.

By application, the research segment dominated the stable isotope labeled compounds market in 2018.

Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.

North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period.

The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Stable Isotope-Labeled Compounds: Market Overview
4.2 North America: Stable Isotope-Labeled Compounds, By Application (2018)
4.3 Geographical Snapshot of the Stable Isotope-Labeled Compounds Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Increase in Research Activities in the Pharmaceutical and Biotechnology Sector Growing Proteomics Research Rising Prevalence of Cancer
5.2.2 Restraints High Cost of Stable Isotope-Labeled Compounds
5.2.3 Opportunities Rising Investments in Pharmaceutical R&D in Emerging Markets
5.2.4 Challenges Dearth of Skilled Professionals

6 Stable Isotope-Labeled Compounds Market, By Type
6.1 Introduction
6.2 Hydrogen-2
6.2.1 Growing Applications of H-2 in Pharmaceutical Research Will Drive Demand for Labeled Compounds
6.3 Carbon-13
6.3.1 Rising Number of Metabolomics Studies and Applications in Disease Diagnosis are Driving Market Growth
6.4 Oxygen-18
6.4.1 Increasing Research on Cancer is Expected to Drive Demand for O-18 Labeled Isotopes
6.5 Nitrogen-15
6.5.1 Expanding Applications of N-15 in Agricultural Investigation and Rising Research are Likely to Drive Market Demand
6.6 Other Stable Isotopes

7 Stable Isotope-Labeled Compounds Market, By Application
7.1 Introduction
7.2 Research
7.2.1 Increasing Research Activities Involving Stable Isotopes to Support Market Growth
7.2.2 Biomedical Research
7.2.3 Pharmaceutical Research
7.2.4 Environmental & Ecological Research
7.2.5 Agricultural Research
7.3 Clinical Diagnostics
7.3.1 Increasing Adoption of Pet Scans and Gamma Imaging for Disease Staging to Support Market Growth
7.4 Industrial Applications
7.4.1 Rising Applications of Stable Isotopes in the Nuclear Industry and the Growing Number of Nuclear Reactors to Support Market Growth
7.5 Other Applications

8 Stable Isotope-Labeled Compounds Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increase in R&D Activities is Expected to Drive Demand for Stable Isotope-Labeled Compounds
8.3 Academic & Research Institutes
8.3.1 Rising Prevalence of Diseases and Growing Research Into Therapies have Driven the Growth of This End-User Segment
8.4 Hospitals & Diagnostic Centers
8.4.1 Adoption of Stable Isotopes has Increased Owing to the Rising Prevalence of Target Diseases
8.5 Other End Users

9 Stable Isotope-Labeled Compounds Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US The US Dominates the North American Market
9.2.2 Canada Availability of Funding Will Drive the Market in Canada
9.3 Europe
9.3.1 Germany Germany is the Fastest-Growing Market in Europe
9.3.2 UK Favorable Scenario for Environmental Research and Increasing Prevalence of Cancer are Key Growth Drivers in the UK
9.3.3 France France has A Large and Well-Developed Biotech Industry
9.3.4 Italy Strong Government Support for Research has Stimulated Market Growth in Italy
9.3.5 Spain Rising Research Activity and Expenditure Shows Significant Market Growth Potential in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China China Dominates the Market in the APAC
9.4.2 Japan Growing Support and Funding have Raised Research Intensity in Japan
9.4.3 India Government Initiatives have Strengthened the Life Science Industry in India
9.4.4 Australia Growing Funding for Research and Collaborations have Supported Market Growth in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (Overall Market) (2018)
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies

11 Company Profiles
11.1 Cambridge Isotope Laboratories
11.2 Merck KGaA
11.3 URENCO Limited
11.4 IsoSciences
11.5 Medical Isotopes
11.6 Omicron Biochemicals
11.7 Trace Sciences International
11.8 Alsachim
11.9 Taiyo Nippon Sanso Corporation
11.10 Perkinelmer
11.11 Rotem Industries Israel
11.12 Boc Sciences
11.13 Cortecnet
11.14 Isoflex
11.15 Huayi Isotopes Co.
11.16 Mesbah Energy Co.
11.17 Shanghai Research Institute of Chemical Industry
11.18 13c Molecular
11.19 C/D/N Isotope
11.20 Shoko Co.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo